IJCS | Volume 31, Nº6, November / December 2018

609 1. Batsis JA, Nieto-Martinez RE, Lopez-Jimenez F. Metabolic syndrome: from global epidemiology to individualized medicine. Clin Pharmacol Ther. 2007;82(5):509-24. 2. González-Rivas J, Molina T. Síndromemetabólico. Med Interna (Caracas). 2011;27(3):156-63. 3. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629-36. 4. Simmons RK, Alberti KG, Gale EA, Colagiuri S, Tuomilehto J, Qiao Q, et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 2010;53(4):600-5. 5. González-Rivas J. Síndrome Metabólico ¿Queda espacio para este concepto? Rev Ven Endocrinol Metab. 2012;10(1):20-7. 6. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735-52. Erratum in: Circulation. 2005;112(17):e298. Circulation. 2005;112(17):e297. 7. Aschner P, Buendia R, Brajkovich I, Gonzalez A, Figueredo R, Juarez XE, et al. Determination of the cutoff point for waist circumference that establishes the presence of abdominal obesity in Latin American men and women. Diabetes Res Clin Pract. 2011;93(2):243-7. 8. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol. 2011;8(4):228-36. 9. Bermudez V, Rojas J, Salazar J, Añez R, Chávez-Castillo M, González R, et al. Optimal waist circumference cut-off point for multiple risk factor aggregation: results from the Maracaibo City Metabolic Syndrome Prevalence Study. Epidemiol Res Internat. 2014;2014:1-9. 10. Florez H, Silva E, Fernandez V, Ryder E, Sulbaran T, Campos G, et al. Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia inWhite, Black, Amerindian andMixedHispanics in Zulia State, Venezuela. Diabetes Res Clin Pract. 2005;69(1):63-77. 11. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-421. 12. Schargrodsky H, Hernandez-Hernandez R, Champagne BM, Silva H, Vinueza R, Silva Aycaguer LC, et al; CARMELA Study Investigators. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med. 2008;121(1):58-65. 13. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5. 14. Uzcategui E, Valery L, Uzcategui L, Gomez Perez R, Marquina D, Baptista T. Prevalence of the metabolic syndrome, insulin resistance index, leptin and thyroid hormone levels in the general population of Merida (Venezuela). Invest Clin. 2015;56(2):169-81. 15. De Oliveria L, García E, Torres J, Rivas A. Prevalencia de síndrome metabólico en el Sector Olivett: El Junquito. Rev Ven Endocrinol Metab. 2006;4(3):33. 16. Marquez-Sandoval F, Macedo-Ojeda G, Viramontes-Horner D, Fernandez Ballart JD, Salas Salvado J, Vizmanos B. The prevalence of metabolic syndrome in LatinAmerica: a systematic review. Public Health Nutr. 2011;14(10):1702-13. 17. de Carvalho Vidigal F, Bressan J, Babio N, Salas-Salvado J. Prevalence of metabolic syndrome in Brazilian adults: a systematic review. BMC Public Health. 2013 Dec 18;13:1198. 18. Wong-McClure RA, Gregg EW, Barcelo A, Lee K, Abarca-Gomez L, Sanabria-Lopez L, et al. Prevalence of metabolic syndrome in Central America: a cross-sectional population-based study. Rev Panam Salud Publica. 2015;38(3):202-8. 19. Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the Metabolic Syndrome in the United States, 2003-2012. JAMA. 2015;313(19):1973-4. 20. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al; Expert Committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of Diabetes Mellitus. Diabetes Care. 2003;26(11):3160-7. 21. Ruiz-Fernández N, Espinoza M, Barrios E, Reigosa A. [Cardiometabolic factors in a comunity located at Valencia city, Venezuela]. Rev Salud Publica (Bogota). 2009;11(3):383-94. 22. WorldHealth Organization (WHO). Venezuela (Bolivarian Republic of): WHO statistical profile 2015. [Accessed in 2017 Jan 10]. Available from: http://www.who.int/countries/ven/en/ 23. Nieto-Martínez R, Hamdy O, Marante D, Marulanda M, Marchetti A, Hegazi R, et al. Transcultural diabetes nutrition algorithm (tDNA): Venezuelan application. Nutrients. 2014;6(4):1333-63. References Brajkovich et al. Metabolic syndrome inVenezuela Int J Cardiovasc Sci. 2018;31(6)603-609 Original Article This is an open-access article distributed under the terms of the Creative Commons Attribution License